BAXTER
LIVE

Serial Number

98416599

Owner

Baxter International Inc.

Attorney

Chloe Hecht

First Use Date

Jan 1, 2023

Filing Date

Feb 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BAXTER Trademark

Serial Number: 98416599 • Registration: 7469039

BAXTER is a trademark filed by Baxter International Inc. on February 22, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015

Entity Type: 03

Trademark Details

Filing Date

February 22, 2024

Registration Date

August 6, 2024

First Use Anywhere

January 1, 2023

First Use in Commerce

January 1, 2023

Published for Opposition

May 21, 2024

Goods & Services

Pharmaceutical products, namely, injection solutions for human use in the treatment of cardiovascular disease; preparations for human health care in the treatment of cardiovascular disease; cardiovascular pharmaceutical preparations; local anesthetics for human use; inhalant anesthetic; pharmaceutical preparations for the induction of local anesthesia; general anesthetics for human use; transdermal patches featuring scopolamine for treatment of nausea and vomiting; antibiotics for human use; sedatives for human use; injectable pharmaceuticals for treatment of infections, bacterial infections, viral infections, pain, fever, hypertension, low blood pressure, heart disease, chest pain, hemodynamic imbalances, blood clots, ulcers, ventricular fibrillation, yeast infections, fungal infections, heart failure, diabetes, cancer, nausea and vomiting, edema, constipation, cirrhosis, opioid overdose, poisoning, heavy bleeding, dehydration, swelling, low magnesium, acne, rapid heartbeats, and low calcium; prescription medicines, namely, pills, tablets, capsules and pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of nausea, vomiting, and damage to bladder; pharmaceutical preparations to temporarily arrest the heart; pharmaceutical preparations for use in cardiac rhythm support; potassium preparations for pharmaceutical purposes; insulin; pharmaceutical preparations, namely, irrigation solutions for flushing, rinsing and cleansing of body tissues, body cavities, and wounds; medical instruments, namely, medical containers and medical bags sold filled with medical liquids and solutions, namely, irrigation solutions for cleansing wounds; amino acid preparations for medical purposes; liquid nutritional supplement; liquid vitamin supplements; saline solution for medical purposes; sterile water for medical purposes

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 6, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 6, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 6, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 6, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 6, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 6, 2026 COAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 9, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 9, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 9, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 9, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 6, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 6, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 11, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 11, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2024 NWOS
NEW APPLICATION ENTERED
Feb 26, 2024 NWAP